(Q43120420)

14 November 2017

title

Dyspeptic symptom development after discontinuation of a proton pump inhibitor: a double-blind placebo-controlled trial (English)

1 reference

14 November 2017

1 reference

3

Magnus Simrén

1 reference

14 November 2017

Anna Niklasson

1

1 reference

14 November 2017

Lina Lindström

series ordinal

2

1 reference

14 November 2017

Greger Lindberg

series ordinal

4

1 reference

14 November 2017

Einar Björnsson

series ordinal

5

1 reference

14 November 2017

language of work or name

English

0 references

publication date

23 March 2010

1 reference

The American Journal of Gastroenterology

14 November 2017

published in

1 reference

14 November 2017

volume

105

1 reference

14 November 2017

issue

7

1 reference

14 November 2017

page(s)

1531-1537

1 reference

Review article: the long-term use of proton-pump inhibitors

14 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.81

Why are patients prescribed proton pump inhibitors? Retrospective analysis of link between morbidity and prescribing in the General Practice Research Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.81

Overuse of acid suppressant drugs in patients with chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.81

Overuse of acid suppressive therapy in hospitalised patients with pulmonary diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.81

Long term acid suppressing treatment in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.81

Rebound nocturnal hypersecretion after four weeks treatment with an H2 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.81

Changes in nocturnal and peak acid outputs after duodenal ulcer healing with sucralfate or ranitidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.81

Rebound intragastric hyperacidity after abrupt withdrawal of histamine H2 receptor blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.81

Marked increase in gastric acid secretory capacity after omeprazole treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.81

Helicobacter pylori eradication releases prolonged increased acid secretion following omeprazole treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.81

Rebound hypersecretion after omeprazole and its relation to on-treatment acid suppression and Helicobacter pylori status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.81

Effect of omeprazole--a gastric proton pump inhibitor--on pentagastrin stimulated acid secretion in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.81

Optimal dose of oral omeprazole for maximal 24 hour decrease of intragastric acidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.81

Duration of effect of lansoprazole on gastric pH and acid secretion in normal male volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.81

Systematic review: Rebound acid hypersecretion after therapy with proton pump inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.81

Validated accuracy of a novel urea breath test for rapid Helicobacter pylori detection and in-office analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.81

Current problems in the measurement of gastrin release. A reproducible measure of physiological gastrin release

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.81

Proton-pump inhibitor therapy induces acid-related symptoms in healthy volunteers after withdrawal of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.81

Rebound acid hypersecretion after long-term inhibition of gastric acid secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.81

Serum chromogranin A as a screening test for gastric enterochromaffin-like cell hyperplasia during acid-suppressive therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.81

Serum chromogranin A in the control of patients on long-term treatment with inhibitors of acid secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.81

Discontinuation of proton pump inhibitors in patients on long-term therapy: a double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.81

Persistence and adherence to proton pump inhibitors in daily clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.81

21 January 2018

Identifiers

DOI

10.1038/AJG.2010.81

1 reference

14 November 2017

1 reference